2020
DOI: 10.1016/j.toxac.2020.09.063
|View full text |Cite
|
Sign up to set email alerts
|

Oxomémazine chez les moins de deux ans : à propos d’un cas de mort inattendue du nourrisson

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In our study we observe age-related contraindication as the main reason in children aged 3 years of age or less. The effect of PPIs is significant because phenothiazines are considered to be possible risk factors in the occurrence of sudden infant death syndrome [ 34 ]. The same is true for the camphor-based combination for bronchial decongestion, which is strictly contraindicated before 6 years of age due to the presence of terpene derivatives that lower the seizure threshold [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…In our study we observe age-related contraindication as the main reason in children aged 3 years of age or less. The effect of PPIs is significant because phenothiazines are considered to be possible risk factors in the occurrence of sudden infant death syndrome [ 34 ]. The same is true for the camphor-based combination for bronchial decongestion, which is strictly contraindicated before 6 years of age due to the presence of terpene derivatives that lower the seizure threshold [ 35 ].…”
Section: Discussionmentioning
confidence: 99%